Skip to content

References

  1. CDC website, https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_atrial_fibrillation.htm
  2. “Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2 DS2 -VASc Score for Thromboembolic Risk Assessment Analysis From the National Cardiovascular Data Registry’s Outpatient Practice Innovation and Clinical Excellence Atrial Fibrillation Registry”, Circ Cardiovasc Qual Outcomes is available at http://circoutcomes.ahajournals.org DOI: 10.1161/CIRCOUTCOMES.116.003476.
  3. Redfors, Björn, et al. “Patients with atrial fibrillation who are not on anticoagulant treatment due to increased bleeding risk are common and have a high risk of stroke.” JACC: Clinical Electrophysiology 3.12 (2017): 1369-1376.
  4. January, Craig T., et al. “2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.” Journal of the American College of Cardiology 64.21 (2014): e1-e76.
  5. https://my.clevelandclinic.org/health/diseases/16765-atrial-fibrillation-afib.
  6. Go et al, prevalence of diagnosed atrial fibrillation in adults, jama, may 9 2001, vol 285, no 18.
  7. Blackshear, Joseph L., and John A. Odell. “Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation.” The Annals of thoracic surgery 61.2 (1996): 755-759.
  8. https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_atrial_fibrillation.htm
  9. S.S. Chugh, R. Havmoeller, K. Narayanan, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 study. Circulation, 129 (2014), pp. 837-847